Clear Harbor Asset Management LLC Has $941,000 Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Clear Harbor Asset Management LLC lifted its position in IQVIA Holdings Inc. (NYSE:IQV) by 1.3% in the third quarter, HoldingsChannel.com reports. The firm owned 3,969 shares of the medical research company’s stock after acquiring an additional 50 shares during the period. Clear Harbor Asset Management LLC’s holdings in IQVIA were worth $941,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Park Place Capital Corp acquired a new position in IQVIA during the third quarter worth $28,000. Versant Capital Management Inc increased its position in IQVIA by 733.3% in the 2nd quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 110 shares in the last quarter. Opal Wealth Advisors LLC bought a new position in IQVIA in the 2nd quarter worth approximately $27,000. Itau Unibanco Holding S.A. acquired a new position in shares of IQVIA during the second quarter valued at $29,000. Finally, International Assets Investment Management LLC bought a new position in IQVIA in the second quarter valued at about $32,000. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analyst Ratings Changes

IQV has been the subject of several recent research reports. Argus raised IQVIA to a “strong-buy” rating in a report on Wednesday, July 31st. Truist Financial dropped their price target on shares of IQVIA from $300.00 to $286.00 and set a “buy” rating for the company in a research note on Monday, October 14th. StockNews.com cut shares of IQVIA from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd. Jefferies Financial Group cut shares of IQVIA from a “buy” rating to a “hold” rating and dropped their target price for the company from $266.00 to $242.00 in a research report on Wednesday, July 24th. Finally, JPMorgan Chase & Co. decreased their price objective on IQVIA from $288.00 to $279.00 and set an “overweight” rating for the company in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $267.27.

IQVIA Price Performance

Shares of NYSE IQV opened at $214.63 on Monday. The company has a fifty day moving average price of $237.63 and a 200 day moving average price of $230.43. The firm has a market cap of $39.11 billion, a PE ratio of 29.32, a PEG ratio of 2.22 and a beta of 1.49. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 1.80. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $261.73.

Insider Buying and Selling at IQVIA

In related news, insider Eric Sherbet sold 1,300 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the transaction, the insider now owns 19,536 shares of the company’s stock, valued at approximately $4,812,302.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.60% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.